NPM1 and acute myeloid leukemia: A retrospective study by Lachowiez et al. also showed that patients of an age > 65 and NPM1-mutated AML treated with HMA/VEN had a higher OS compared to those treated with HMA monotherapy or intensive chemotherapy [65].